Press releases

All press releases Regulatory

Regulatory press release 2025-06-27

Xspray Pharma Passes FDA Pre-Approval Inspection – Key Regulatory Milestone Achieved for Dasynoc

Regulatory press release 2025-05-14

FDA sets PDUFA-date for Xspray Pharma’s re-submitted application for Dasynoc®

Regulatory press release 2025-05-13

Bulletin from the annual general meeting of Xspray Pharma AB (publ)

Regulatory press release 2025-05-07

Interim Report First Quarter 2025

Regulatory press release 2025-04-10

Notice of annual general meeting of Xspray Pharma AB (publ)

Regulatory press release 2025-03-27

Xspray Pharma AB publishes its Annual Report for 2024

Regulatory press release 2025-02-12

Interim Report Fourth Quarter 2024

Regulatory press release 2024-12-30

New number of shares and votes in Xspray Pharma after rights issue

Regulatory press release 2024-12-04

Xspray publishes the final outcome of the rights issue

Regulatory press release 2024-12-02

Strong interest in Xspray Pharma AB’s rights issue – preliminary outcome is published

IR contact

Kerstin Hasselgren, IRO / Senior Adviser

+46 (0)70 311 16 83

info@xspray.com

Subscribe